Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 6/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 4/20 | 0.33 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1741585 | 0.83 | TSHR (0.32) | TSHR | |
| SCHEMBL176693 | 0.83 | — | — | |
| SCHEMBL334918 | 0.82 | CA2 (0.48) | TSHRUSP2ALDH1A1TP53CA2 | |
| SCHEMBL8841243 | 0.80 | GRIK1 (0.32) | TSHR | |
| Ammonia Solution, Strong SCHEMBL10336370 | 0.80 | — | — | |
| SCHEMBL28365073 | 0.78 | TSHR (0.40) | TSHRUSP2ALDH1A1TP53CA2 | |
| SCHEMBL8589382 | 0.77 | TSHR (0.44) | TSHRALDH1A1TP53CA2CA1 | |
| SCHEMBL8228378 | 0.77 | CA1 (0.39) | TSHRUSP2ALDH1A1CA2CA1 | |
| SCHEMBL27662647 | 0.77 | CA2 (0.48) | TSHRALDH1A1TP53CA2MAPK1 | |
| SCHEMBL31595979 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 680 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117866071-A | Preparation method of protein iron succinate | 圣嘉(滨海)生物医药科技有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-114773588-A | DBCO modified polyethylene glycol linking agent and synthesis method thereof | 武汉翱飞科技有限公司 | 2022-07-22 | — | — | CN | claimed |
| US-20020045751-A1 | Thyromimetic organic compounds | NOVARTIS AG (CH) | 2002-04-18 | — | — | US | claimed |
| EP-0303279-B1 | Reactive hindered amine light stabilizers | ATOCHEM NORTH AMERICA ELF (US) | 1996-09-25 | — | — | EP | claimed |
| EP-0410970-B1 | REACTIVE HINDERED AMINE LIGHT STABILIZERS | ATOCHEM NORTH AMERICA ELF (US) | 1996-08-14 | — | — | EP | claimed |
| US-5214147-A | Reacting piperdinyl half-ester half-amide with hydrazine; heat and light stabilizers for anhydride copolymers by chemical attachment of hydrazide functional group | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1993-05-25 | — | — | US | claimed |
| EP-0440329-A1 | S-substituted carbonyl substituted betathioacrylamide biocides and fungicides | ROHM AND HAAS COMPANY (US) | 1991-08-07 | — | — | EP | claimed |
| EP-0303279-A2 | Reactive hindered amine light stabilizers | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1989-02-15 | — | — | EP | claimed |
| US-4219641-A | Process for preparing erythromycin succinate | THE UPJOHN COMPANY (US) | 1980-08-26 | — | — | US | claimed |
| JP-5001093-A | — | — | None | — | — | JP | disclosed |
| CN-117720466-B | 2 '-Acetyl-2', 3 '-dihydro-4'H-spiro [ cyclohexane-1, 1 '-isoquinoline ] -4' -ketone compound and preparation method and application thereof | 承德医学院 | 2026-05-19 | — | — | CN | disclosed |
| US-12459940-B2 | Oxazole compound as multi-targeted inhibitor of IRAK4 and BTK | Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. (CN) | 2025-11-04 | — | — | US | disclosed |
| EP-3998264-B1 | OXAZOLE COMPOUND AS MULTI-TARGETED INHIBITOR OF IRAK4 AND BTK | SHANGHAI FOSUN PHARMACEUTICAL IND DEVELOPMENT CO LTD (CN) | 2025-08-20 | — | — | EP | disclosed |
| EP-4573086-A1 | METHANOGEN INHIBITORS | Agrizeronz Limited Partnership (NZ) | 2025-06-25 | — | — | EP | disclosed |
| EP-0013107-A1 | 16-Hydroxy-16-vinyl (or cyclopropyl)-prostan-1-ols and pharmaceutical compositions containing the same | AMERICAN CYANAMID COMPANY (US) | 1980-07-09 | — | — | EP | disclosed |
| US-4206151-A | BRONCHODILATOR, ANTISECRETORY, HYPOTENSIVE | AMERICAN CYANAMID COMPANY (US) | 1980-06-03 | — | — | US | disclosed |
| US-4201866-A | ADRENERGIC BLOCKING AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1980-05-06 | — | — | US | disclosed |
| US-4165365-A | ANTIALLERGENS ESPECIALLY FOR ASTHMA | SMITHKLINE CORPORATION (US) | 1979-08-21 | — | — | US | disclosed |
| EP-0002590-A1 | Novel prostaglandin compounds, processes for the preparation thereof and pharmaceutical compositions containing them | AMERICAN CYANAMID COMPANY (US) | 1979-06-27 | — | — | EP | disclosed |
| US-4136100-A | BLUE-VIOLET TO GREEN-BLUE DYEINGS ON CELLULOSE TEXTILES | BASF AKTIENGESELLSCHAFT (DE) | 1979-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12459940-B2 | Oxazole compound as multi-targeted inhibitor of IRAK4 and BTK | IRAK4, IRAK2, IRAK3 | TSHR 3616/4885USP2 1843/4885ALDH1A1 3215/4885 |
| US-20020045751-A1 | Thyromimetic organic compounds | TPO, THRA, LPO | TSHR 14/4885USP2 3872/4885ALDH1A1 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.